Work

Abstract CT133: Association of programmed death-ligand 1 (PD-L1) and 2 (PD-L2) expression with nivolumab (NIVO) efficacy in advanced melanoma (MEL)

Year: 2016

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2016-ct133

Authors: Scott J. Rodig, Evisa Gjini, Kaushal Desai, Chelsea Jin, Christine Horak, Mary Ruisi, Jeffrey Weber, Gordon J. Freeman, F. Stephen Hodi

Institutions: Dana-Farber Cancer Institute, Bristol-Myers Squibb (United States), NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2498328577

Cites:

Cited by: 2

Related to: 10